Merck is reportedly nearing an agreement to acquire Cidara Therapeutics, in a deal that would value the biotechnology firm above its current $3.3 billion market capitalization
Sun Pharmaceutical Industries Limited (Sun Pharma), India’s leading pharmaceutical company by revenue and prescriptions, has rolled out the #SeeBeyondSugar campaign — a national initiative aimed at boosting awareness and education around diabetic
.png "Abbott Unveils New Ensure Diabetes Care Formula in India")
Abbott has introduced an improved brand of its India Diabetes Care form of the brand, Sure, focusing on science-based nutrition to individuals with diabetes. Today, the launch was announced, and is based on the results of more than 30 years of...
Indian pharma major Lupin announced today the U.S. launch of Risperidone extended-release injectable suspension in 25 mg, 37.5 mg and 50 mg single-dose vials, marking a significant strategic move in the long-acting injectable (LAI) market...
Novartis announced positive Phase III results on its innovative malaria drug GanLum. This research, referred to as KALUMA, demonstrated that GanLum achieved its primary objective and was as effective, at least, as existing standard therapies...
CN Tech Engineers (CN Water), a major Indian provider of high-purity water solutions for pharmaceutical and industrial use, has entered into a strategic alliance with Taiwan Pure Water Technology Co., Ltd. (Taipure), a leader in ultrapure water (UPW)
The US Food and Drug Administration (USFDA) has finally approved Alembic Pharmaceuticals' Abbreviated New Drug Application (ANDA) for Dexlansoprazole Delayed-Release Capsules
India has achieved a great step forward in the production of CAR-T therapy with the introduction of the first hands-on cell and gene therapy training course. The collaboration between Miltenyi Biotec, the Translational Health Science and Technology..
The highly anticipated 3rd Edition of PACK.Nxt returns to The Lalit in Mumbai on 16th December 2025, the only dedicated event on Smart & Sustainable Packaging in India.
Shilpa Medicare announced favorable topline Phase 3 results of its new drug OERIS (Ondansetron Extended Release Injection). OERIS is a weekly medication that is used to prevent chemotherapy-induced nausea and vomiting (CINV). The multicentric...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")